US Stock MarketDetailed Quotes
CPIX Cumberland Pharmaceuticals
- 1.250
- -0.050-3.85%
Close Dec 3 16:00 ET
- 1.230
- -0.020-1.62%
Post 18:39 ET
17.55MMarket Cap-1642P/E (TTM)
1.370High1.200Low120.27KVolume1.370Open1.300Pre Close149.02KTurnover1.53%Turnover RatioLossP/E (Static)14.04MShares2.35952wk High0.71P/B9.83MFloat Cap1.04052wk Low--Dividend TTM7.86MShs Float17.750Historical High--Div YieldTTM13.08%Amplitude1.040Historical Low1.239Avg Price1Lot Size
Cumberland Pharmaceuticals Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -61.55%475.5K | -116.34%-855.66K | -50.66%-2.14M | -27.91%6.09M | -71.41%1.04M | -53.08%1.24M | 124.64%5.24M | -842.34%-1.42M | 94.41%8.45M | 149.80%3.64M |
| Net income from continuing operations | -44.56%-1.54M | -227.89%-1.1M | -1,204.25%-1.9M | -12.05%-6.33M | -156.21%-6.3M | -151.22%-1.06M | 163.18%862.15K | 112.28%172.29K | -56.82%-5.65M | 36.67%-2.46M |
| Operating gains losses | ---- | ---- | ---- | --20.26K | ---- | ---- | ---- | ---- | ---- | ---- |
| Depreciation and amortization | -5.75%1.4M | -4.84%1.42M | 0.56%1.44M | 8.30%5.77M | 165.65%1.36M | -3.74%1.49M | -7.49%1.5M | -13.66%1.43M | 15.67%5.33M | -52.51%511.48K |
| Other non cash items | -3.50%-798.66K | -111.38%-179.37K | 83.38%-355.84K | 19.06%-1.71M | 67.96%-373.41K | 11.39%-771.65K | 334.80%1.58M | -459.95%-2.14M | 37.69%-2.11M | 6.66%-1.17M |
| Change In working capital | -11.37%1.33M | -189.05%-1.07M | -44.00%-1.39M | -55.61%4.63M | -56.24%2.9M | -31.64%1.5M | -56.71%1.2M | 16.36%-967.33K | 27.63%10.44M | 25.30%6.62M |
| -Change in receivables | 666.56%309.14K | -271.63%-795.18K | -321.42%-1.07M | 155.68%3.4M | 21.54%2.51M | 97.95%-54.56K | -79.23%463.31K | 106.21%481.61K | -211.19%-6.12M | -30.41%2.07M |
| -Change in inventory | -126.28%-170.95K | 1,073.11%1.07M | 152.69%170.47K | -102.54%-23.14K | -3.20%-441.5K | 140.39%650.47K | -86.51%91.45K | -114.24%-323.56K | -81.08%911.08K | -118.92%-427.8K |
| -Change in payables and accrued expense | -16.99%1.26M | -185.82%-1.28M | 41.59%-645.54K | -74.38%3.72M | -68.37%1.82M | -63.19%1.52M | 655.79%1.49M | -124.77%-1.11M | 2,018.72%14.54M | 172.09%5.76M |
| -Change in other current assets | 144.36%598.03K | -48.47%219.07K | -46.40%205.62K | -90.47%65.68K | 73.06%-987.75K | -92.18%244.73K | -56.94%425.09K | 59.93%383.61K | 2,037.87%689.26K | -120.46%-3.67M |
| -Change in other current liabilities | 22.36%-664.19K | 77.43%-286.56K | 85.86%-57.1K | -704.49%-2.54M | -100.27%-7.71K | -9.08%-855.5K | 3.57%-1.27M | -8.76%-403.74K | 131.23%419.66K | 822.73%2.89M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -61.55%475.5K | -116.34%-855.66K | -50.66%-2.14M | -27.91%6.09M | -71.41%1.04M | -53.08%1.24M | 124.64%5.24M | -842.34%-1.42M | 33.28%8.45M | 85.64%3.64M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 299.47%189.64K | 51.65%-46.8K | 66.65%-58.19K | 99.23%-105.7K | 140.68%260.64K | -113.96%-95.07K | 43.91%-96.81K | 98.71%-174.45K | -2,624.58%-13.67M | -2,291.39%-640.77K |
| Net PPE purchase and sale | 71.06%-15.38K | 90.06%-7.18K | 61.20%-41.62K | -175.35%-281.27K | -131.70%-48.67K | 41.88%-53.14K | 47.40%-72.19K | -297.47%-107.26K | 1.34%-102.15K | 1,797.00%153.53K |
| Net intangibles purchase and sale | 22.41%-32.54K | -60.98%-39.63K | 75.35%-16.57K | 91.29%-171.78K | 97.88%-38.04K | 67.01%-41.93K | 30.34%-24.62K | -350.60%-67.19K | -685.74%-1.97M | -2,451.73%-1.79M |
| Net business purchase and sale | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- | ---13.5M | --0 |
| Net other investing changes | ---- | ---- | ---- | -81.71%347.36K | ---- | ---- | ---- | ---- | 3,513.07%1.9M | 295.93%1M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 299.47%189.64K | 51.65%-46.8K | 66.65%-58.19K | 99.23%-105.7K | 140.68%260.64K | -113.96%-95.07K | 43.91%-96.81K | 98.71%-174.45K | -2,624.58%-13.67M | -2,291.39%-640.77K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 39.18%-536.84K | 90.55%-309.58K | 236.12%2.42M | -260.10%-7.42M | 46.52%-1.49M | 55.67%-882.6K | -171.12%-3.28M | -145.41%-1.78M | 41.98%-2.06M | -278.19%-2.78M |
| Net issuance payments of debt | --0 | 100.25%7.45K | 2,683.90%3.3M | -384.65%-3.42M | 90.73%-138.98K | 82.69%-225K | -192.42%-2.92M | -102.55%-127.71K | --1.2M | ---1.5M |
| Net common stock issuance | 51.00%-98.82K | 17.54%-134.25K | -32.33%-247.61K | 29.68%-740.53K | 0.36%-188.97K | -168.56%-201.65K | 21.80%-162.79K | 67.75%-187.12K | 24.07%-1.05M | 47.49%-189.66K |
| Net other financing activities | 3.93%-438.02K | 3.13%-182.78K | 56.93%-630.7K | -47.96%-3.27M | -6.23%-1.16M | 25.99%-455.94K | ---188.68K | -191.98%-1.46M | -1.94%-2.21M | -191.67%-1.09M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 39.18%-536.84K | 90.55%-309.58K | 236.12%2.42M | -260.10%-7.42M | 46.52%-1.49M | 55.67%-882.6K | -171.12%-3.28M | -145.41%-1.78M | 41.98%-2.06M | -278.19%-2.78M |
| Net cash flow | ||||||||||
| Beginning cash position | -5.00%17.34M | 13.20%18.55M | -7.27%18.32M | -26.93%19.76M | -5.29%18.51M | 0.18%18.25M | -5.10%16.39M | -26.93%19.76M | 9.24%27.04M | -24.38%19.54M |
| Current changes in cash | -50.44%128.31K | -165.06%-1.21M | 106.73%226.86K | 80.28%-1.44M | -186.10%-186.34K | -80.46%258.88K | 96.14%1.86M | 65.50%-3.37M | -418.44%-7.28M | -81.93%216.43K |
| End cash Position | -5.64%17.46M | -5.00%17.34M | 13.20%18.55M | -7.27%18.32M | -7.27%18.32M | -5.29%18.51M | 0.18%18.25M | -5.10%16.39M | -26.93%19.76M | -26.93%19.76M |
| Free cash flow | -62.54%427.59K | -117.56%-902.46K | -37.81%-2.19M | -11.58%5.64M | -52.26%953.4K | -52.77%1.14M | 138.12%5.14M | -727.80%-1.59M | 6.54%6.38M | 6.22%2M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
